Clinical Trials · NCT04060043

Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer

CompletedEARLY_Phase 1Gonadorelin (Approved)
Phase
EARLY_Phase 1
Recruitment status
Completed
Sponsor
CMX Research
Enrollment
11
Start date
Feb 2017
Locations
7 sites, Canada, Georgia
Primary endpoint
Changes in testosterone levels
View Gonadorelin compound reference